Special issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity report

Although several centers are now performing allogeneic hematopoietic SCT (HSCT) in the Eastern Mediterranean (EM) region, the availability is still limited. Special issues including compatible donor availability and potential for alternative donor programs are discussed. In comparison to Europe and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bone marrow transplantation (Basingstoke) 2009-01, Vol.43 (1), p.1-12
Hauptverfasser: Aljurf, M D, Zaidi, S Z, El Solh, H, Hussain, F, Ghavamzadeh, A, Mahmoud, H K, Shamsi, T, Othman, T Ben, Sarhan, M M, Dennison, D, Ibrahim, A, Benchekroun, S, Chaudhri, N, Labar, B, Horowitz, M, Niederwieser, D, Gratwohl, A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 12
container_issue 1
container_start_page 1
container_title Bone marrow transplantation (Basingstoke)
container_volume 43
creator Aljurf, M D
Zaidi, S Z
El Solh, H
Hussain, F
Ghavamzadeh, A
Mahmoud, H K
Shamsi, T
Othman, T Ben
Sarhan, M M
Dennison, D
Ibrahim, A
Benchekroun, S
Chaudhri, N
Labar, B
Horowitz, M
Niederwieser, D
Gratwohl, A
description Although several centers are now performing allogeneic hematopoietic SCT (HSCT) in the Eastern Mediterranean (EM) region, the availability is still limited. Special issues including compatible donor availability and potential for alternative donor programs are discussed. In comparison to Europe and North America, differences in patterns of diseases and pre-HSCT general status, particularly for patients with BM failure, are described. Other differences including high sero-positivity for CMV, hepatitis B and C infection, and specific observations about GVHD and its relation to genetically homogeneous communities are also discussed. We report that a total of 17 HSCT programs (performing five or more HSCTs annually) exist in 9 countries of the EM region. Only six programs are currently reporting to European Group for Blood and Marrow Transplantation or Center for International Blood and Marrow Transplantation Research. A total of 7617 HSCTs have been performed by these programs including 5701 allogeneic HSCTs. The area has low-HSCT team density (1.56 teams per 10 million inhabitants vs 14.43 in Europe) and very low-HSCT team distribution (0.27 teams per 10 000 sq km area vs
doi_str_mv 10.1038/bmt.2008.389
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_66823236</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A192640036</galeid><sourcerecordid>A192640036</sourcerecordid><originalsourceid>FETCH-LOGICAL-c586t-9a7b00935f3783453b4d0b624bf0723a3c608fe1ae7c5aa0aadb6cc39f42c8d53</originalsourceid><addsrcrecordid>eNptkk1v1DAQhi0EokvhxhlZIHoii2MnTnKsVqVFKuLQcrYmznjXVRIH26nUf493N6IU1T7YGj8zno-XkPc5W-dM1F_bIa45Y_Va1M0LssqLSmalkOVLsmJc1pkQsjkhb0K4YywvCla-Jid5wwpRlHJF7m8m1BZ6akOYMVCPPUTsaHR0hwNENzmL0Wp6s7mldqRxh_QCQkQ_0h_Y2XTxMCKMyXNr3Uhh7A6QsT7ExZjCg4723saHZJmcj2_JKwN9wHfLeUp-fbu43Vxl1z8vv2_OrzNd1jJmDVQtY40ojajqlLBoi461khetYRUXILRktcEcsNIlAAPoWqm1aEzBdd2V4pScHeNO3v1O9UU12KCx71PObg5KypoLLmQCP_4H3rnZp8yD4rlMizU8QZ-O0BZ6VHY0LnrQ-4jqPG-4LBg7hFo_Q6Xd4WC1G9HYZH_icPaPww6hj7vg-jmm1oWn4JcjqL0LwaNRk7cD-AeVM7UXg0piUHsxqCSGhH9YaprbAbtHeJl-Aj4vAAQNvUmT1Db85XjOpRQHLjtyIT2NW_SPzXn24z_cxMov</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>216666092</pqid></control><display><type>article</type><title>Special issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity report</title><source>MEDLINE</source><source>Nature Journals Online</source><source>EZB-FREE-00999 freely available EZB journals</source><source>SpringerLink Journals - AutoHoldings</source><creator>Aljurf, M D ; Zaidi, S Z ; El Solh, H ; Hussain, F ; Ghavamzadeh, A ; Mahmoud, H K ; Shamsi, T ; Othman, T Ben ; Sarhan, M M ; Dennison, D ; Ibrahim, A ; Benchekroun, S ; Chaudhri, N ; Labar, B ; Horowitz, M ; Niederwieser, D ; Gratwohl, A</creator><creatorcontrib>Aljurf, M D ; Zaidi, S Z ; El Solh, H ; Hussain, F ; Ghavamzadeh, A ; Mahmoud, H K ; Shamsi, T ; Othman, T Ben ; Sarhan, M M ; Dennison, D ; Ibrahim, A ; Benchekroun, S ; Chaudhri, N ; Labar, B ; Horowitz, M ; Niederwieser, D ; Gratwohl, A</creatorcontrib><description>Although several centers are now performing allogeneic hematopoietic SCT (HSCT) in the Eastern Mediterranean (EM) region, the availability is still limited. Special issues including compatible donor availability and potential for alternative donor programs are discussed. In comparison to Europe and North America, differences in patterns of diseases and pre-HSCT general status, particularly for patients with BM failure, are described. Other differences including high sero-positivity for CMV, hepatitis B and C infection, and specific observations about GVHD and its relation to genetically homogeneous communities are also discussed. We report that a total of 17 HSCT programs (performing five or more HSCTs annually) exist in 9 countries of the EM region. Only six programs are currently reporting to European Group for Blood and Marrow Transplantation or Center for International Blood and Marrow Transplantation Research. A total of 7617 HSCTs have been performed by these programs including 5701 allogeneic HSCTs. The area has low-HSCT team density (1.56 teams per 10 million inhabitants vs 14.43 in Europe) and very low-HSCT team distribution (0.27 teams per 10 000 sq km area vs &lt;1–6 teams in Europe). Gross national income per capita had no clear association with low-HSCT activity. Much improvement in infrastructure and formation of an EM regional HSCT registry are needed.</description><identifier>ISSN: 0268-3369</identifier><identifier>EISSN: 1476-5365</identifier><identifier>DOI: 10.1038/bmt.2008.389</identifier><identifier>PMID: 19043456</identifier><identifier>CODEN: BMTRE9</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Analysis ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Bone marrow ; Bone Marrow Transplantation ; Bone marrow, stem cells transplantation. Graft versus host reaction ; Cell Biology ; Data Collection ; Health Services Accessibility ; Hematology ; Hematopoietic Stem Cell Transplantation - utilization ; Hematopoietic stem cells ; Humans ; Internal Medicine ; Management ; Medical care, Cost of ; Medical centers ; Medical sciences ; Medicine ; Medicine &amp; Public Health ; Mediterranean Region ; Polymorphism, Genetic ; Public Health ; Registries ; special-report ; Stem cell transplantation ; Stem Cells ; Tissue Donors - supply &amp; distribution ; Transfusions. Complications. Transfusion reactions. Cell and gene therapy ; Transplantation ; Transplantation Conditioning - utilization</subject><ispartof>Bone marrow transplantation (Basingstoke), 2009-01, Vol.43 (1), p.1-12</ispartof><rights>Macmillan Publishers Limited 2009</rights><rights>2009 INIST-CNRS</rights><rights>COPYRIGHT 2009 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Jan 2009</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c586t-9a7b00935f3783453b4d0b624bf0723a3c608fe1ae7c5aa0aadb6cc39f42c8d53</citedby><cites>FETCH-LOGICAL-c586t-9a7b00935f3783453b4d0b624bf0723a3c608fe1ae7c5aa0aadb6cc39f42c8d53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/bmt.2008.389$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/bmt.2008.389$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21266356$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19043456$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aljurf, M D</creatorcontrib><creatorcontrib>Zaidi, S Z</creatorcontrib><creatorcontrib>El Solh, H</creatorcontrib><creatorcontrib>Hussain, F</creatorcontrib><creatorcontrib>Ghavamzadeh, A</creatorcontrib><creatorcontrib>Mahmoud, H K</creatorcontrib><creatorcontrib>Shamsi, T</creatorcontrib><creatorcontrib>Othman, T Ben</creatorcontrib><creatorcontrib>Sarhan, M M</creatorcontrib><creatorcontrib>Dennison, D</creatorcontrib><creatorcontrib>Ibrahim, A</creatorcontrib><creatorcontrib>Benchekroun, S</creatorcontrib><creatorcontrib>Chaudhri, N</creatorcontrib><creatorcontrib>Labar, B</creatorcontrib><creatorcontrib>Horowitz, M</creatorcontrib><creatorcontrib>Niederwieser, D</creatorcontrib><creatorcontrib>Gratwohl, A</creatorcontrib><title>Special issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity report</title><title>Bone marrow transplantation (Basingstoke)</title><addtitle>Bone Marrow Transplant</addtitle><addtitle>Bone Marrow Transplant</addtitle><description>Although several centers are now performing allogeneic hematopoietic SCT (HSCT) in the Eastern Mediterranean (EM) region, the availability is still limited. Special issues including compatible donor availability and potential for alternative donor programs are discussed. In comparison to Europe and North America, differences in patterns of diseases and pre-HSCT general status, particularly for patients with BM failure, are described. Other differences including high sero-positivity for CMV, hepatitis B and C infection, and specific observations about GVHD and its relation to genetically homogeneous communities are also discussed. We report that a total of 17 HSCT programs (performing five or more HSCTs annually) exist in 9 countries of the EM region. Only six programs are currently reporting to European Group for Blood and Marrow Transplantation or Center for International Blood and Marrow Transplantation Research. A total of 7617 HSCTs have been performed by these programs including 5701 allogeneic HSCTs. The area has low-HSCT team density (1.56 teams per 10 million inhabitants vs 14.43 in Europe) and very low-HSCT team distribution (0.27 teams per 10 000 sq km area vs &lt;1–6 teams in Europe). Gross national income per capita had no clear association with low-HSCT activity. Much improvement in infrastructure and formation of an EM regional HSCT registry are needed.</description><subject>Analysis</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Bone marrow</subject><subject>Bone Marrow Transplantation</subject><subject>Bone marrow, stem cells transplantation. Graft versus host reaction</subject><subject>Cell Biology</subject><subject>Data Collection</subject><subject>Health Services Accessibility</subject><subject>Hematology</subject><subject>Hematopoietic Stem Cell Transplantation - utilization</subject><subject>Hematopoietic stem cells</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Management</subject><subject>Medical care, Cost of</subject><subject>Medical centers</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Mediterranean Region</subject><subject>Polymorphism, Genetic</subject><subject>Public Health</subject><subject>Registries</subject><subject>special-report</subject><subject>Stem cell transplantation</subject><subject>Stem Cells</subject><subject>Tissue Donors - supply &amp; distribution</subject><subject>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</subject><subject>Transplantation</subject><subject>Transplantation Conditioning - utilization</subject><issn>0268-3369</issn><issn>1476-5365</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNptkk1v1DAQhi0EokvhxhlZIHoii2MnTnKsVqVFKuLQcrYmznjXVRIH26nUf493N6IU1T7YGj8zno-XkPc5W-dM1F_bIa45Y_Va1M0LssqLSmalkOVLsmJc1pkQsjkhb0K4YywvCla-Jid5wwpRlHJF7m8m1BZ6akOYMVCPPUTsaHR0hwNENzmL0Wp6s7mldqRxh_QCQkQ_0h_Y2XTxMCKMyXNr3Uhh7A6QsT7ExZjCg4723saHZJmcj2_JKwN9wHfLeUp-fbu43Vxl1z8vv2_OrzNd1jJmDVQtY40ojajqlLBoi461khetYRUXILRktcEcsNIlAAPoWqm1aEzBdd2V4pScHeNO3v1O9UU12KCx71PObg5KypoLLmQCP_4H3rnZp8yD4rlMizU8QZ-O0BZ6VHY0LnrQ-4jqPG-4LBg7hFo_Q6Xd4WC1G9HYZH_icPaPww6hj7vg-jmm1oWn4JcjqL0LwaNRk7cD-AeVM7UXg0piUHsxqCSGhH9YaprbAbtHeJl-Aj4vAAQNvUmT1Db85XjOpRQHLjtyIT2NW_SPzXn24z_cxMov</recordid><startdate>20090101</startdate><enddate>20090101</enddate><creator>Aljurf, M D</creator><creator>Zaidi, S Z</creator><creator>El Solh, H</creator><creator>Hussain, F</creator><creator>Ghavamzadeh, A</creator><creator>Mahmoud, H K</creator><creator>Shamsi, T</creator><creator>Othman, T Ben</creator><creator>Sarhan, M M</creator><creator>Dennison, D</creator><creator>Ibrahim, A</creator><creator>Benchekroun, S</creator><creator>Chaudhri, N</creator><creator>Labar, B</creator><creator>Horowitz, M</creator><creator>Niederwieser, D</creator><creator>Gratwohl, A</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7QP</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20090101</creationdate><title>Special issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity report</title><author>Aljurf, M D ; Zaidi, S Z ; El Solh, H ; Hussain, F ; Ghavamzadeh, A ; Mahmoud, H K ; Shamsi, T ; Othman, T Ben ; Sarhan, M M ; Dennison, D ; Ibrahim, A ; Benchekroun, S ; Chaudhri, N ; Labar, B ; Horowitz, M ; Niederwieser, D ; Gratwohl, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c586t-9a7b00935f3783453b4d0b624bf0723a3c608fe1ae7c5aa0aadb6cc39f42c8d53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Analysis</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Bone marrow</topic><topic>Bone Marrow Transplantation</topic><topic>Bone marrow, stem cells transplantation. Graft versus host reaction</topic><topic>Cell Biology</topic><topic>Data Collection</topic><topic>Health Services Accessibility</topic><topic>Hematology</topic><topic>Hematopoietic Stem Cell Transplantation - utilization</topic><topic>Hematopoietic stem cells</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Management</topic><topic>Medical care, Cost of</topic><topic>Medical centers</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Mediterranean Region</topic><topic>Polymorphism, Genetic</topic><topic>Public Health</topic><topic>Registries</topic><topic>special-report</topic><topic>Stem cell transplantation</topic><topic>Stem Cells</topic><topic>Tissue Donors - supply &amp; distribution</topic><topic>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</topic><topic>Transplantation</topic><topic>Transplantation Conditioning - utilization</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aljurf, M D</creatorcontrib><creatorcontrib>Zaidi, S Z</creatorcontrib><creatorcontrib>El Solh, H</creatorcontrib><creatorcontrib>Hussain, F</creatorcontrib><creatorcontrib>Ghavamzadeh, A</creatorcontrib><creatorcontrib>Mahmoud, H K</creatorcontrib><creatorcontrib>Shamsi, T</creatorcontrib><creatorcontrib>Othman, T Ben</creatorcontrib><creatorcontrib>Sarhan, M M</creatorcontrib><creatorcontrib>Dennison, D</creatorcontrib><creatorcontrib>Ibrahim, A</creatorcontrib><creatorcontrib>Benchekroun, S</creatorcontrib><creatorcontrib>Chaudhri, N</creatorcontrib><creatorcontrib>Labar, B</creatorcontrib><creatorcontrib>Horowitz, M</creatorcontrib><creatorcontrib>Niederwieser, D</creatorcontrib><creatorcontrib>Gratwohl, A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Bone marrow transplantation (Basingstoke)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aljurf, M D</au><au>Zaidi, S Z</au><au>El Solh, H</au><au>Hussain, F</au><au>Ghavamzadeh, A</au><au>Mahmoud, H K</au><au>Shamsi, T</au><au>Othman, T Ben</au><au>Sarhan, M M</au><au>Dennison, D</au><au>Ibrahim, A</au><au>Benchekroun, S</au><au>Chaudhri, N</au><au>Labar, B</au><au>Horowitz, M</au><au>Niederwieser, D</au><au>Gratwohl, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Special issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity report</atitle><jtitle>Bone marrow transplantation (Basingstoke)</jtitle><stitle>Bone Marrow Transplant</stitle><addtitle>Bone Marrow Transplant</addtitle><date>2009-01-01</date><risdate>2009</risdate><volume>43</volume><issue>1</issue><spage>1</spage><epage>12</epage><pages>1-12</pages><issn>0268-3369</issn><eissn>1476-5365</eissn><coden>BMTRE9</coden><abstract>Although several centers are now performing allogeneic hematopoietic SCT (HSCT) in the Eastern Mediterranean (EM) region, the availability is still limited. Special issues including compatible donor availability and potential for alternative donor programs are discussed. In comparison to Europe and North America, differences in patterns of diseases and pre-HSCT general status, particularly for patients with BM failure, are described. Other differences including high sero-positivity for CMV, hepatitis B and C infection, and specific observations about GVHD and its relation to genetically homogeneous communities are also discussed. We report that a total of 17 HSCT programs (performing five or more HSCTs annually) exist in 9 countries of the EM region. Only six programs are currently reporting to European Group for Blood and Marrow Transplantation or Center for International Blood and Marrow Transplantation Research. A total of 7617 HSCTs have been performed by these programs including 5701 allogeneic HSCTs. The area has low-HSCT team density (1.56 teams per 10 million inhabitants vs 14.43 in Europe) and very low-HSCT team distribution (0.27 teams per 10 000 sq km area vs &lt;1–6 teams in Europe). Gross national income per capita had no clear association with low-HSCT activity. Much improvement in infrastructure and formation of an EM regional HSCT registry are needed.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>19043456</pmid><doi>10.1038/bmt.2008.389</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0268-3369
ispartof Bone marrow transplantation (Basingstoke), 2009-01, Vol.43 (1), p.1-12
issn 0268-3369
1476-5365
language eng
recordid cdi_proquest_miscellaneous_66823236
source MEDLINE; Nature Journals Online; EZB-FREE-00999 freely available EZB journals; SpringerLink Journals - AutoHoldings
subjects Analysis
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Biological and medical sciences
Bone marrow
Bone Marrow Transplantation
Bone marrow, stem cells transplantation. Graft versus host reaction
Cell Biology
Data Collection
Health Services Accessibility
Hematology
Hematopoietic Stem Cell Transplantation - utilization
Hematopoietic stem cells
Humans
Internal Medicine
Management
Medical care, Cost of
Medical centers
Medical sciences
Medicine
Medicine & Public Health
Mediterranean Region
Polymorphism, Genetic
Public Health
Registries
special-report
Stem cell transplantation
Stem Cells
Tissue Donors - supply & distribution
Transfusions. Complications. Transfusion reactions. Cell and gene therapy
Transplantation
Transplantation Conditioning - utilization
title Special issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity report
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T10%3A48%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Special%20issues%20related%20to%20hematopoietic%20SCT%20in%20the%20Eastern%20Mediterranean%20region%20and%20the%20first%20regional%20activity%20report&rft.jtitle=Bone%20marrow%20transplantation%20(Basingstoke)&rft.au=Aljurf,%20M%20D&rft.date=2009-01-01&rft.volume=43&rft.issue=1&rft.spage=1&rft.epage=12&rft.pages=1-12&rft.issn=0268-3369&rft.eissn=1476-5365&rft.coden=BMTRE9&rft_id=info:doi/10.1038/bmt.2008.389&rft_dat=%3Cgale_proqu%3EA192640036%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=216666092&rft_id=info:pmid/19043456&rft_galeid=A192640036&rfr_iscdi=true